Raymond James Financial Services Advisors, Inc. Spectrum Pharmaceuticals Inc Transaction History

Raymond James Financial Services Advisors, Inc.

  • $73.5 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 25, 2023
BUY
$0.65 - $1.31 $5,268 - $10,618
8,106 Added 63.8%
20,812 $19,000
Q1 2023

Apr 14, 2023
BUY
$0.38 - $1.07 $77 - $217
203 Added 1.62%
12,706 $9,000
Q4 2022

Feb 08, 2023
SELL
$0.32 - $0.52 $137 - $224
-431 Reduced 3.33%
12,503 $4,000
Q3 2022

Oct 25, 2022
BUY
$0.43 - $1.56 $94 - $341
219 Added 1.72%
12,934 $6,000
Q4 2020

Feb 12, 2021
SELL
$3.38 - $5.14 $5,915 - $8,995
-1,750 Reduced 12.1%
12,715 $43,000
Q3 2019

Nov 07, 2019
BUY
$7.03 - $9.7 $101,688 - $140,310
14,465 New
14,465 $120,000

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0
View Full List

About SPECTRUM PHARMACEUTICALS INC

SPPI Quotes by TradingView
  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email